Parkinson’s disease affects 7 to 10 million people worldwide and is the second most frequent neurodegenerative disease after Alzheimer’s. Significant advances have been made over the past two decades both in the understanding of the mechanisms underlying the disease and in patient management.
This session is designed as an interface between clinicians and researchers. Its aim is to provide updates on Parkinson’s disease from pathophysiology to treatment. The lectures are all given by leaders in their respective fields. Being organized by the ICN PhD program, this session is primarily aimed for students (Master, PhD, Med School, Neurology Residents).
